Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre <i>et al</i>' by Cheng and Zhang.

Della-Torre, Emanuel; Landoni, Giovanni; Zangrillo, Alberto; Dagna, Lorenzo

Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al' by Cheng and Zhang.

Della-Torre, Emanuel; Landoni, Giovanni; Zangrillo, Alberto; Dagna, Lorenzo.

Della-Torre E; Università Vita-Salute San Raffaele, San Raffaele Scientific Institute, Milano, Italy dellatorre.emanuel@hsr.it.
Landoni G; Unit of Immunology, Rheumatology, Allergy, and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy.
Zangrillo A; Università Vita-Salute San Raffaele, San Raffaele Scientific Institute, Milano, Italy.
Dagna L; Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milan, Italy.

Ann Rheum Dis ; 81(10): e197, 2022 10.

Article in English | MEDLINE | ID: covidwho-724297

Subject(s)

COVID-19 Drug Treatment; Interleukin-6; Antibodies, Monoclonal, Humanized; Cohort Studies; Humans; Respiration, Artificial

Keywords

biological therapy; cytokines; inflammation

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / COVID-19 Drug Treatment Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2022 Document Type: Article Affiliation country: Annrheumdis-2020-218724

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google